We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > sIPV

News List

Intravacc's Inactivated Polio Vaccine Out-licensed to Sinovac contractpharma
July 21, 2021
Sinovac's Eupolio vaccine (sIPV) receives market authorization from the NMPA in China.
Univercells Introduces Vaccine Manufacturing Platform americanpharmaceuticalreview
January 14, 2019
Univercells announced the commercial launch of its proprietary NevoLine bioproduction system for vaccines. The system was initially developed as part of a $12 million Grand Challenges grant awarded by .....
Sinovac Announces Preliminary Results of Phase III Trial on sIPV biospace
April 20, 2018
Sinovac Biotech Ltd. today announced preliminary results of a phase III clinical study on Sabin inactivated polio vaccine ("sIPV") developed by Sinovac Biotech Co., Ltd. ("Sinovac Beijing") on the unblinding conference held on April 19, 2018.